HUTCHMED (China) (HCM) Share-based Compensation (2018 - 2021)
HUTCHMED (China) (HCM) posted quarterly Share-based Compensation of $5.0 million for Q2 2021, up 87.03% year-over-year from $2.7 million in Q2 2020, and up 68.83% quarter-over-quarter from $2.9 million in Q1 2021.
HUTCHMED (China) (HCM) Share-based Compensation (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has reported Share-based Compensation for 4 consecutive years, with $5.0 million the latest figure, recorded in Q2 2021.
- In Q2 2021, Share-based Compensation rose 87.03% year-over-year to $5.0 million; the TTM figure through Jun 2021 stood at $10.9 million (up 80.62% YoY), while the FY2025 annual figure was $2.5 million, down 18.12% from the prior year.
- Share-based Compensation advanced to $5.0 million in Q2 2021 per HCM's latest filing, from $2.9 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $5.0 million in Q2 2021 and bottomed at $334000.0 in Q1 2018.
- Historically, Share-based Compensation has averaged $2.2 million across 4 years, with a median of $2.3 million in 2018.
- Annual changes were most pronounced in 2020 — Share-based Compensation plunged 84.97% — and 2021, when it surged 754.49%.
- HUTCHMED (China)'s Share-based Compensation stood at $2.8 million in 2018, then sank by 36.52% to $1.8 million in 2019, then jumped by 51.11% to $2.7 million in 2020, then jumped by 87.03% to $5.0 million in 2021.
- Business Quant data shows HCM's Share-based Compensation at $5.0 million in Q2 2021, $2.9 million in Q1 2021, and $2.7 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | HUTCHMED (China) | 2.18 Bn | 2.18 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 4.98 Mn |
| Jun 30, 2021 | 4.98 Mn |
| Mar 31, 2021 | 2.95 Mn |
| Mar 31, 2021 | 2.95 Mn |
| Jun 30, 2020 | 2.66 Mn |
| Jun 30, 2020 | 2.66 Mn |
| Mar 31, 2020 | 345,000.00 |
| Mar 31, 2020 | 345,000.00 |
| Dec 31, 2019 | 1.76 Mn |
| Dec 31, 2019 | 1.76 Mn |
| Sep 30, 2019 | 1.29 Mn |
| Sep 30, 2019 | 1.29 Mn |
| Jun 30, 2019 | 1.83 Mn |
| Jun 30, 2019 | 1.83 Mn |
| Mar 31, 2019 | 2.30 Mn |
| Mar 31, 2019 | 2.30 Mn |
| Dec 31, 2018 | 2.77 Mn |
| Dec 31, 2018 | 2.77 Mn |
| Sep 30, 2018 | 2.34 Mn |
| Sep 30, 2018 | 2.34 Mn |